This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.
Sunday, 8 September 2019
Developers get open source boost for data privacy protection
Google has announced that it is releasing the open-source version of a differential privacy library that helps power some of its own products.
France says 1,500 died in summer's heat wave
France's health minister says 1,500 people died in this summer's heat wave in France—but a campaign of public awareness saved many lives.
India locates lander lost on final approach to moon
The lander module from India's moon mission was located on the lunar surface on Sunday, one day after it lost contact with the space station, and efforts are underway to try to establish contact with it, the head of the nation's space agency said.
Powerful typhoon Faxai pummels Tokyo region
Typhoon Faxai, upgraded to a "very strong" storm with potentially record winds and rain, battered the Tokyo region late Sunday, sparking evacuation warnings to tens of thousands and transport disruption.
New KEYNOTE 021 data shows no association with tumor mutational burden
Researchers had previously reported data from the KEYNOTE 021 trial that showed antitumor activity for pembrolizumab plus platinum-based chemotherapy in untreated advanced nonsquamous non-small cell lung cancer patients. Today at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer, the same research group presented new data from two new groups of patients from this trial.
Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients
Combining the PD-1 immune check point inhibitor nivolumab with the monoclonal antibody ipilimumab showed a consistent safety profile in special populations with advanced non-small cell lung cancer (NSCLC), according to research presented today by at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer.
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer
A clinical trial testing the toxicity of a KRAS inhibitor demonstrated early promising antitumor activity and few adverse side effects in patients with advanced non-small cell lung cancer harboring KRAS G12C mutation, according to research presented today at the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
Share of women seeking out-of-state abortions increases
At a routine ultrasound when she was five months pregnant, Hevan Lunsford began to panic when the technician took longer than normal, then told her she would need to see a specialist.
A Purdue bankruptcy would make opioids cases even messier
State and local governments have sought billions of dollars from Purdue Pharma as a way to hold the company and the family that owns it accountable for the nation's opioid epidemic, a potential payout that is now clouded in uncertainty after state attorneys general said settlement talks had broken down.
No added dizzy episodes for adults on more intensive blood pressure-lowering treatment
Adults who received more intensive treatment to lower their blood pressure were less likely to experience drastic blood pressure drops, which can cause dizziness and increase risk of falling, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.
Native Hawaiians lowered blood pressure with hula dancing
Native Hawaiians who participated in a blood-pressure-lowering program incorporating their cultural dance of hula lowered their blood pressure more than those who received standard education on diet and exercise, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.
Arm cuff BP measurements may fall short for predicting heart disease risk in some people with resistant high BP
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.
One-third of young children admitted to intensive care for sepsis show PTSD symptoms years later
Doctors have found that children who have been in Intensive Care Units (ICUs) for sepsis have a significantly increased risk of Post-Traumatic Stress Disorder (PTSD), with around 1/3 showing PTSD symptoms. In some young people, these may persist for years following discharge. There is some evidence that these children have altered immune responses during their stay in ICU and this may be a risk factor for later PTSD symptom development, but this needs to be confirmed.
Deep magnet stimulation shown to improve symptoms of obsessive compulsive disorder
Researchers have found that focusing powerful non-invasive magnet stimulation on a specific brain area can improve the symptoms of Obsessive Compulsive Disorder (OCD). This opens the way to treat the large minority of sufferers who do not respond to conventional treatment. The work is presented at the ECNP Conference in Copenhagen.
Stripped-back auto show mirrors German car industry gloom
Frankfurt's biennial International Auto Show (IAA) opens its doors to the public Thursday, but major foreign carmakers are staying away while climate demonstrators march outside—forming a microcosm of the industry's woes.
iPhone to share the spotlight with services at Apple's big event
The iPhone will be front and center at Apple's upcoming media presentation even as the California tech giant steps up its efforts in content and services for its devices.
Smooth succession: Jack Ma eases out of a thriving Alibaba
Jack Ma steps down next week as chairman of Alibaba, but the start-up he built into an online retail behemoth is expected to keep thriving into a new era thanks to a culture of innovation he helped nurture.
Email: Opioid talks fail, Purdue bankruptcy filing expected
OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation's deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday.
E-bike grumbles echo in the Bavarian Alps
Robert Werner and his wife Ursula usually make time to say a friendly hello to hikers as they ride their gently whirring e-bikes up trails in the Bavarian Alps.
Subscribe to:
Posts (Atom)